Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2016

Filed with the SEC on May 23, 2016 and accepted by EDGAR at May 23, 2016, 21:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-01-01 to 2016-03-31$102us-gaap:SalesRevenueNet
Operating income3 months2016-01-01 to 2016-03-31−$4.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2016-01-01 to 2016-03-31$4.3kus-gaap:InterestExpense
Income tax3 months2016-01-01 to 2016-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-01-01 to 2016-03-31−$9.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2016-01-01 to 2016-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2016-01-01 to 2016-03-31−$5.7kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2016-03-31$1.8kus-gaap:Cash
Current assetsAt period end2016-03-31$1.8kus-gaap:AssetsCurrent
Total assetsAt period end2016-03-31$1.8kus-gaap:Assets
Current liabilitiesAt period end2016-03-31$86.6kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-03-31$86.6kus-gaap:Liabilities
Shareholders' equityAt period end2016-03-31−$84.7kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-16-104276. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.